Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 0: clinchem.2009.124859v1, 2009; 10.1373/clinchem.2009.124859
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
clinchem.2009.124859v1
55/8/1503    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Luan, J.
Right arrow Articles by Ding, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luan, J.
Right arrow Articles by Ding, C.

Received on February 19, 2009
Accepted on May 29, 2009

Automation and Analytical Techniques

Multiplex Detection of 60 Hepatitis B Virus Variants by MALDI-TOF Mass Spectrometry

Ju Luan 1, Jing Yuan 2, Xiaohe Li 2, Shengnan Jin 2, Ling Yu 2, Mingfeng Liao 2, Hongmei Zhang 2, Cheng Xu 2, Qing He 2, Bin Wen 2, Xunhua Zhong 2, Xinchun Chen 2, Henry L.Y. Chan 3, Joseph J.Y. Sung 3, Boping Zhou 2, Chunming Ding 4*

1 Stanley Ho Centre for Emerging Infectious Diseases and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR
2 Shenzhen–Hong Kong Institute of Infectious Disease, Third People's Hospital of Shenzhen, Shenzhen, Guangdong, P.R. China
3 Department of Medicine and Therapeutics, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR
4 Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research, Singapore

* To whom correspondence should be addressed. E-mail: cmding{at}gmail. com.

BACKGROUND: Variations in the hepatitis B virus (HBV) genome may develop spontaneously or under selective pressure from antiviral therapy. Such variations may confer drug resistance or affect virus replication capacity, resulting in failure of antiviral therapy.

METHODS: A duplex PCR was used to amplify the region of the reverse transcriptase gene, the precore promoter, and the basal core promoter of the HBV genome. Four multiplex primer-extension reactions were used to interrogate 60 frequently observed HBV variants during antiviral therapy. Automated MALDI-TOF mass spectrometry (MS) was used for mutation detection. Capillary sequencing was used to confirm the MS results.

RESULTS: The limit of quantification was 1000 HBV copies/mL for multiplex detection of HBV variants. Fifty-three variants (88.3%) were analyzed successfully in at least 90% of the sera from 88 treatment-naive patients and 80 patients with virologic breakthrough. MS was able to detect twice as many minor variants as direct sequencing while achieving close to full automation. MS and direct sequencing showed only 0.1% discordance in variant calls.

CONCLUSIONS: This platform based on multiplex primer extension and MALDI-TOF MS was able to detect 60 HBV variants in 4 multiplex reactions with accuracy and low detection limits.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the American Association for Clinical Chemistry.